Logo

Caprotec Bioanalytics

String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms
Premium

While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.

Caprotec Signs Plant Proteomics Research Deal with Syngenta

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research agreement with Syngenta to profile the interactions of one of Syngenta's active compounds with the proteome of certain relevant plant systems.

Caprotec Enters Second Collaboration with Bayer CropScience for Use of CCMS Technology

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.

People in the News: BG Medicine, Caprotec, and More
Premium

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

Caprotec, Bayer CropScience Reach Screening Deal

NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.